Jennifer Viera | Senior Director, IR & Corporate Communications |
Jay Luly | President, CEO & Director |
Paul Mellett | SVP, Finance & Administration and CFO |
Roy Buchanan | JMP Securities |
Yasmeen Rahimi | Piper Sandler |
Eric Joseph | JP Morgan |
Jay Olson | Oppenheimer |
Good afternoon and welcome to Enanta Pharmaceuticals fiscal fourth quarter and year-end 2020, financial results call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of the prepared remarks. Please be advised that this call is being recorded. I would now like to turn the call over to Jennifer Viera, Senior Director, Investor Relations.